4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-20-034065
Chief Medical Officer gave up 24,045 shares (to pay taxes)
- Chief Medical Officer acquired 87,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gordon David N. Chief Medical Officer | 2020-06-01 | Option exercise | +87,500 | 106,940 | D | ||
| Gordon David N. Chief Medical Officer | 2020-06-01 | Shares withheld for taxes | −24,045 | $1.32 | $31,739 | 82,895 | D |
| Derivatives | |||||||
| Gordon David N. Chief Medical Officer | 2020-06-01 | Option exercise · Restricted stock units | −87,500 | 87,500 | D | ||
Loading xslF345X03/doc4.xml…